title: Perturbations of plasma cortisol and DHEA-S following discontinuation of cocaine use in cocaine addicts.
abstract: Changes in plasma levels of cortisol and dehydroepiandrosterone sulfate (DHEA-S) following cocaine discontinuation were assessed in hospitalized chronic cocaine users. Measurements were performed after 6, 9, 18 and 21 days of abstinence. Repeated measures ANOVAs revealed significant time effects for cortisol (P<0.02) and DHEA-S (P<0.001). Changes in the two hormones did not follow the same course. Levels of cortisol were highest on day 6 and then subsequently decreased, whereas DHEA-S levels were low on day 6 and highest on day 18. Repeated measures ANCOVAs were used to test the overall effects of total duration of cocaine use, daily or weekly cocaine amounts consumed, or frequency of use on cortisol secretion. Analyses revealed a significant effect of frequency of use only (P<0.04). More sustained cocaine use was associated with higher cortisol levels and less pronounced cortisol decline after discontinuation of cocaine use, but drug intake variables had no influence on DHEA-S. The effects of presence or absence of life-long histories of aggression were also assessed. Repeated measures ANOVAs revealed a near significant group x time interaction for cortisol, which declined more dramatically in aggressive addicts than in non-aggressive addicts after day 6. DHEA-S was consistently higher in aggressive cocaine addicts, although this effect did not reach statistical significance. There was a noticeable difference in the dynamics of normalization of adrenal hormones between the two groups, with DHEA-S/cortisol ratios rising more dramatically during cocaine abstinence in aggressive than in non-aggressive addicts. In conclusion, lingering neuroendocrine perturbations persist after discontinuation of cocaine use in addicts. Some of these changes could be associated with an increased relapse risk.
authors.affiliation: New York Harbor Healthcare System, Brooklyn Campus, 800 Poly Place, Brooklyn, NY 11209, USA. lbuydens@worldnet.att.net
authors.forename: Laure
authors.initials: L
authors.lastname: Buydens-Branchey
authors.forename: Marc
authors.initials: M
authors.lastname: Branchey
authors.forename: Jeffrey
authors.initials: J
authors.lastname: Hudson
authors.forename: Maria
authors.initials: M
authors.lastname: Dorota Majewska
mesh_terms: D000328:Adult; D000374:Aggression; D019970:Cocaine-Related Disorders / Q000097:blood* / Q000523:psychology; D019314:Dehydroepiandrosterone Sulfate / Q000097:blood*; D006801:Humans; D006854:Hydrocortisone / Q000097:blood*; D008297:Male; D010879:Piperazines / Q000097:blood; D011569:Psychiatric Status Rating Scales; D017366:Serotonin Receptor Agonists / Q000097:blood; D013375:Substance Withdrawal Syndrome / Q000097:blood* / Q000523:psychology
chemical_list: D010879:Piperazines; D017366:Serotonin Receptor Agonists; D019314:Dehydroepiandrosterone Sulfate; C015068:1-(3-chlorophenyl)piperazine; D006854:Hydrocortisone